Finance

Beta
Lists
PMDI:OTCMKTS
Psychemedics Corp
$2.20
0.00%
(0.00) 1D
Jun 1, 9:30:10 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMDI...
Mkt. cap
13.44M
Avg. vol.
1.79K
Volume
0.00
52-wk high
$2.50
52-wk low
$1.33
Beta
0.60
Shares outstanding
6.11M
No. of employees
101
Mkt. cap
13.44M
Avg. vol.
1.79K
Volume
0.00
52-wk high
$2.50
52-wk low
$1.33
Beta
0.60
Shares outstanding
6.11M
No. of employees
101
News stories
From sources across the web
Profile
Psychemedics Corporation is a United States corporation which provides patented, FDA-cleared, CAP certified clinical laboratory services for the detection of drugs of abuse. The company's corporate headquarters are located in Acton, Massachusetts and its laboratory operations are located in Culver City, California. Wikipedia
About Psychemedics Corp
CEORaymond C Kubacki Jr
Employees101
Founded1986
HeadquartersActon, Massachusetts, United States
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Revenue
5.36M
4.73M
5.18M
4.42M
Cost of goods sold
3.24M
3.18M
3.14M
3.04M
Cost of revenue
3.24M
3.18M
3.14M
3.04M
Research and development expenses
209.00K
189.00K
172.00K
179.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.48M
2.26M
2.46M
1.04M
Operating expense
2.69M
2.45M
2.63M
1.22M
Total operating expenses
5.92M
5.63M
5.77M
4.26M
Operating income
-567.00K
-899.00K
-595.00K
168.00K
Other non operating income
-3.00K
27.00K
2.00K
1.00K
EBT including unusual items
-572.00K
-898.00K
-606.00K
160.00K
EBT excluding unusual items
-570.00K
-898.00K
-606.00K
160.00K
Income tax expense
116.00K
-71.00K
-71.00K
-29.00K
Effective tax rate
-20.28%
7.91%
11.72%
-18.12%
Other operating expenses
-
-
-
-
Net income
-688.00K
-827.00K
-535.00K
189.00K
Net profit margin
-12.84%
-17.49%
-10.34%
4.27%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-26.00K
-13.00K
-9.00K
Net interest expenses
-
-26.00K
-13.00K
-9.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-246.00K
-595.00K
-302.00K
267.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more